mail
versión imprimible
 
 

3rd CRISPR 2.0 Summit 2022

Evvnt Promotion / evvnt
-
29.11.2022 - 01.12.2022  Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 08:30 - 17:00
 
Temas de la conferencia
Recognised with a Nobel Prize in 2020, CRISPR has opened the floodgates for a new era of gene editing therapies, promising to transform genetic disease treatments. With a well-established early field of genomics research, drug developers and researchers have been busy establishing the next-generation CRISPR toolkit, including Cas nucleases, base and prime editing technologies, and innovative delivery platforms.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/1278515-2?pid=4832

Speakers: Aditya Raguram, PhD Student David Liu Lab, Harvard University, Alexandra Crawley, Co-Founder and Senior Scientist, LifeEDIT, Amy Simon, Chief Medical Officer, Beam Therapeutics, and more.
 

Información e inscripción:

https://go.evvnt.com/1278515-3?pid=4832
Ms. Min Ratcliffe
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2499.00 - USD 4897.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Helix - Forschung & Beratung WienAGEM - Arbeitsgemeinschaft Ethnologie und MedizinÖsterreichische Gesellschaft für Public HealthEuropean Public Health Association (EUPHA)Alumni Club Medizinische Universität WienCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÄrztekammer für WienAnästhesie in Entwicklungsländern e. V.